CSF3 and acute myeloid leukemia: The European Organization for Research and Treatment of Cancer (EORTC)/Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) AML-13 trial [29] investigated the impact of G-CSF on efficacy and toxicity when given in induction chemotherapy in elderly AML patients.